Institutional Ownership Neurocrine Biosciences Inc (NBIX)
This table provides information about the institutional ownership of Neurocrine Biosciences Inc (NBIX). We have compiled data on the 654 institutions that hold shares in the stock, with a total of 96.5 Million shares, which have been reported (via 13F filing form) to have a value of $11.5 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Scout Investments, Inc.
|
Nov 12, 2024 Q3 2024 |
203,501
shares
|
$24.2 Million
0.69% of portfolio
|
Q3 2024
Added 7.18%
|
|
|
Envestnet Asset Management Inc
|
Feb 12, 2025 Q4 2024 |
203,210
shares
|
$24.2 Million
0.01% of portfolio
|
Q4 2024
Reduced 12.99%
|
|
|
Logos Global Management LP
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
200,000
shares
|
$23.8 Million
3.59% of portfolio
|
Q4 2024
New holding
|
|
|
George Soros
Soros Fund Management LLC | New York, Ny
|
Feb 14, 2025 Q4 2024 |
200,000
shares
|
$23.8 Million
0.68% of portfolio
|
Q4 2024
Added 33.33%
|
|
|
Balyasny Asset Management LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
194,728
shares
|
$23.2 Million
0.04% of portfolio
|
Q4 2024
New holding
|
|
|
Victory Capital Management Inc
|
Feb 06, 2025 Q4 2024 |
189,896
shares
|
$22.6 Million
0.03% of portfolio
|
Q4 2024
Reduced 7.01%
|
|
|
Skandinaviska Enskilda Banken Ab (Publ)
Stockholm, V7 |
Feb 10, 2025 Q4 2024 |
180,406
shares
|
$21.5 Million
0.11% of portfolio
|
Q4 2024
Reduced 40.63%
|
|
|
Barclays PLC
London, X0 |
Feb 13, 2025 Q4 2024 |
178,368
shares
|
$21.2 Million
0.01% of portfolio
|
Q4 2024
Reduced 1.77%
|
|
|
New York State Common Retirement Fund
|
Jan 31, 2025 Q4 2024 |
177,774
shares
|
$21.2 Million
0.03% of portfolio
|
Q4 2024
Reduced 1.11%
|
|
|
Ensign Peak Advisors, Inc
Salt Lake City, UT |
Feb 13, 2025 Q4 2024 |
173,694
shares
|
$20.7 Million
0.04% of portfolio
|
Q4 2024
Reduced 0.65%
|
|
|
Credit Suisse Ag
Zurich, V8 |
May 10, 2024 Q1 2024 |
169,161
shares
|
$20.1 Million
0.02% of portfolio
|
Q1 2024
Reduced 15.5%
|
|
|
Neuberger Berman Group LLC
New York, NY |
Feb 13, 2025 Q4 2024 |
168,176
shares
|
$20 Million
0.02% of portfolio
|
Q4 2024
Added 5.41%
|
|
|
Pfm Health Sciences, LP
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
166,803
shares
|
$19.9 Million
1.49% of portfolio
|
Q4 2024
New holding
|
|
|
Citigroup Inc
|
Feb 12, 2025 Q4 2024 |
165,180
shares
|
$19.7 Million
0.01% of portfolio
|
Q4 2024
Reduced 17.62%
|
|
|
Glenmede Trust CO Na
Philadelphia, PA |
Feb 14, 2025 Q4 2024 |
163,356
shares
|
$19.5 Million
0.12% of portfolio
|
Q4 2024
Added 1492.01%
|
|
|
Integral Health Asset Management, LLC
|
Feb 14, 2025 Q4 2024 |
160,000
shares
|
$19.1 Million
1.95% of portfolio
|
Q4 2024
New holding
|
|
|
Abrdn PLC
|
Jan 24, 2025 Q4 2024 |
156,574
shares
|
$18.6 Million
0.04% of portfolio
|
Q4 2024
Added 14.77%
|
|
|
Eagle Health Investments LP
Greenwich, CT |
Feb 12, 2025 Q4 2024 |
155,000
shares
|
$18.5 Million
5.2% of portfolio
|
Q4 2024
Added 20.53%
|
|
|
Worldquant Millennium Advisors LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
154,852
shares
|
$18.4 Million
0.14% of portfolio
|
Q4 2024
Added 44.07%
|
|
|
Sei Investments CO
Oaks, PA |
Feb 11, 2025 Q4 2024 |
150,424
shares
|
$17.9 Million
0.03% of portfolio
|
Q4 2024
Reduced 3.03%
|
|
|
Massachusetts Financial Services CO
Boston, MA |
Feb 12, 2025 Q4 2024 |
150,331
shares
|
$17.9 Million
0.01% of portfolio
|
Q4 2024
Reduced 7.8%
|
|
|
Tang Capital Management LLC
San Diego, CA |
Feb 14, 2025 Q4 2024 |
150,000
shares
|
$17.9 Million
1.54% of portfolio
|
Q3 2024
New holding
|
|
|
Man Group PLC
London, X0 |
Feb 14, 2025 Q4 2024 |
145,164
shares
|
$17.3 Million
0.06% of portfolio
|
Q4 2024
Reduced 50.99%
|
|
|
Qube Research & Technologies LTD
London, X0 |
Feb 14, 2025 Q4 2024 |
145,111
shares
|
$17.3 Million
0.03% of portfolio
|
Q4 2024
Reduced 80.99%
|
|
|
Banco Bilbao Vizcaya Argentaria, S.A.
|
Feb 14, 2025 Q4 2024 |
139,670
shares
|
$16.6 Million
0.2% of portfolio
|
Q4 2024
Added 0.66%
|